Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Delayed Quote USD

VanEck Pharmaceutical ETF (PPH)

83.04
+2.32
+(2.87%)
At close: April 9 at 4:00:03 PM EDT
83.10
+0.06
+(0.07%)
After hours: April 9 at 5:53:35 PM EDT

Top 10 Holdings (59.30% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 11.90%
JNJ
Johnson & Johnson 6.62%
ABBV
AbbVie Inc. 6.56%
NVS
Novartis AG 5.23%
AZN
AstraZeneca PLC 4.93%
COR
Cencora, Inc. 4.92%
SNY
Sanofi 4.89%
MRK
Merck & Co., Inc. 4.83%
MCK
McKesson Corporation 4.74%
NVO
Novo Nordisk A/S 4.68%

Sector Weightings

SectorPPH
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.97%
Bonds 0.00%

Equity Holdings

Price/Earnings 0.04
Price/Book 0.3
Price/Sales 0.83
Price/Cashflow 0.08
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

ETF Overview

Category Health
Fund Family VanEck
Net Assets 668.74M
YTD Daily Total Return -5.89%
Yield 1.87%
Legal Type Exchange Traded Fund

Related Tickers